Novavax Stock News

Novavax (NASDAQ: NVAX ) stock was among the laggards in the race for the vaccine against COVID-19. Unsurprisingly, NVAX stock plunged from highs of $320 in 2021 to recent lows of $3.5.

While it tends to fly under the radar for many people, the biotech industry has seen a resurgence in investor interest over the last couple of years. While there could be several reasons for this, s

Novavax just signed a lucrative agreement with a biotech giant. Inovio Pharmaceuticals is inching closer to launching its leading candidate.

Novavax stock surged after the company announced a partnership with pharma giant Sanofi. The biotech stock has spent the past few years in the doldrums after sales of its coronavirus vaccine disappoin

Novavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company. This withdrawal is in sync with the company?

The price-action in some speculative stocks in the recent past is signaling the possible return of the meme stock euphoria. Stocks like Novavax (NASDAQ: NVAX ) doubled overnight, and the rally has eve

GameStop (NYSE: GME ) and AMC (NYSE: AMC ) meme stocks rose substantially last week, gaining over 70%. The return of ‘Roaring Kitty', prominent investor Keith Gill, has traders wondering which meme

Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's board, after the COVID-19 vaccine maker struck a licensing deal with Sanof

May 20 (Reuters) - Hedge fund Shah Capital said on Monday that it was withdrawing its preliminary proxy statement and its campaign against the re-election of three directors on Novavax's board. Shah C

May 20 (Reuters) - Hedge fund Shah Capital said on Monday that it was withdrawing its preliminary proxy statement and its campaign against the re-election of three directors on Novavax's board. Shah C

Novavax recently entered into a lucrative, multitiered deal with Sanofi. The agreement helps improve Novavax's prospects.

Novavax reached a deal with Sanofi recently which sent the stock soaring. The company now expects to generate up to $1.2 billion in revenue this year.

The stock price of Novavax (NASDAQ: NVAX), a Covid-19 vaccine developer, trades at $13 per share, about 96% below its peak level of $320 seen in February 2021. NVAX stock was trading at around $51 in

The meme stock season seems to be back. Novavax (NASDAQ: NVAX ) has surged over 200% in the last month, with big gains coming in a few trading days.

Moderna's sales soared into the billions as it conquered the coronavirus vaccine market -- and today the company promises to deliver many new products in the near term. Novavax struggled in recent tim